VFA
NXTM

Virtus Fund Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Virtus Fund Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,603
Closed -$366K – 542
2017
Q2 		$366K Sell
14,603
-6,326
-30% -$157K ﹤0.01% 350
2017
Q1 		$562K Sell
20,929
-6,698
-24% -$185K 0.01% 311
2016
Q4 		$724K Sell
27,627
-5,212
-16% -$129K 0.01% 295
2016
Q3 		$821K Sell
32,839
-5,657
-15% -$132K 0.01% 286
2016
Q2 		$850K Hold
38,496
– – 0.01% 283
2016
Q1 		$577K Sell
38,496
-8,402
-18% -$141K 0.01% 332
2015
Q4 		$1.03M Sell
46,898
-492
-1% -$9.17K 0.01% 280
2015
Q3 		$747K Buy
+47,390
New +$760K 0.01% 314
2014
Q3 		– Sell
-5,240
Closed -$75K – 2314
2014
Q2 		$75K Buy
+5,240
New +$68.4K ﹤0.01% 1601

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Virtus Fund Advisers's NXTM Position: Q3 2017 in Review

Virtus Fund Advisers sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 14,603 shares — an estimated $366K sold.

Virtus Fund Advisers first reported a position in NXTM in Q2 2014 and held it in 9 quarters. The position peaked at $1.03M in Q4 2015. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Virtus Fund Advisers reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Virtus Fund Advisers sold 14,603 NxStage Medical Inc. shares in Q3 2017, an estimated $366K.
  • Virtus Fund Advisers first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 9 quarters.
  • Virtus Fund Advisers's NxStage Medical Inc. position peaked at $1.03M in Q4 2015.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Virtus Fund Advisers's 13F filing for Q3 2017, filed 13 Nov 2017.